Brian Baker

Brian joined Erasca as senior vice president of finance. With more than 25 years of industry experience, he has provided executive level financial expertise to both public and private biotechnology companies, including Turning Point Therapeutics (TPTX), Cleave Biosciences and Phenomix Corporation. Prior to Erasca, Brian most recently served as senior vice president of finance and administration at TPTX, where he led all corporate accounting, finance and planning activities. He played a key role in TPTX’s growth from a small private company into a multibillion-dollar public company and helped complete five financings with combined proceeds in excess of $1.3 billion, including a $191 million initial public offering in April 2019.

Brian earned his B.S. and M.S. degrees from San Diego State University and is an active certified public accountant in the state of California.